Skip to main content
SupplementScience

NMN vs NR (Nicotinamide Riboside)

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

Both NMN and NR effectively raise NAD+ levels in humans. NR has more published clinical trials and is generally cheaper, while NMN is one enzymatic step closer to NAD+ and may be slightly more efficient at raising NAD+ in some tissues. For most people, consistent daily use of either precursor at the right dose matters more than which one you choose.

Head-to-Head Comparison

CriteriaNMNNR (Nicotinamide Riboside)Winner
NAD+ Raising EfficacyStrong — significant NAD+ elevation at 250-500mg in RCTsStrong — significant NAD+ elevation at 300-1000mg in RCTsTie
Biosynthetic DirectnessOne step from NAD+ — NMN is converted directly to NAD+ by NMNAT enzymesTwo steps from NAD+ — NR must first be converted to NMN, then to NAD+NMN
Clinical Evidence VolumeGrowing — 10+ human trials publishedMore extensive — 20+ human trials, longer track recordNR (Nicotinamide Riboside)
StabilityLess stable — sensitive to heat and humidityMore stable — NR chloride form has better shelf stabilityNR (Nicotinamide Riboside)
Cost$0.75-1.50/day for 250-500mg$0.50-1.00/day for 300-500mgNR (Nicotinamide Riboside)

Detailed Analysis

NAD+ Raising Efficacy

Both NMN and NR reliably raise blood NAD+ levels in human trials. Yi et al. (2022) showed NMN at 250mg raised NAD+ significantly over 12 weeks. Martens et al. (2018) demonstrated NR at 500mg increased NAD+ by 60% in 6 weeks. Head-to-head human comparisons are limited, making it difficult to declare a clear winner on NAD+ elevation alone.

Biosynthetic Directness

NMN is one enzymatic step closer to NAD+ in the salvage pathway. NR requires two conversions: NR to NMN (via NRK enzymes) and then NMN to NAD+ (via NMNAT). In theory, this gives NMN a more direct route, though a dedicated NMN transporter (Slc12a8) in the gut remains debated. Some researchers argue NMN may need to be converted to NR for cellular uptake in certain tissues.

Clinical Evidence Volume

NR (primarily as Niagen by ChromaDex) entered the human trial space earlier and has accumulated more published studies, including larger and longer-duration trials. NMN trials have accelerated since 2021 but still represent a smaller evidence base. NR also has more safety data from extended supplementation periods.

Stability

NMN can degrade in warm or humid conditions, requiring careful storage and sometimes refrigeration. NR in its chloride salt form (Niagen) is generally more shelf-stable under normal conditions. This is a practical consideration for daily supplementation, especially in warm climates.

Cost

NR is generally cheaper per effective dose due to longer market presence and ChromaDex's established supply chain. NMN prices have decreased significantly as more manufacturers have entered the market, but it remains slightly more expensive on average.

Our Verdict

Both NMN and NR are legitimate NAD+ precursors with clinical evidence supporting their efficacy. NR has the edge in evidence volume, stability, and cost. NMN has a theoretical advantage in biosynthetic directness. For most people, the choice matters less than consistent daily supplementation with a verified-purity product at the right dose. If you already take one and it is working well, there is no compelling reason to switch.

Learn more about
NMN

Frequently Asked Questions

Should I switch from NR to NMN?

If you are taking NR and seeing benefits (subjective energy, lab markers), there is no strong evidence that switching to NMN will provide additional improvement. Both raise NAD+ through overlapping pathways. The theoretical advantage of NMN's more direct conversion has not translated into a measurable clinical advantage in head-to-head studies. Stick with what works for you.

Can I take NMN and NR together?

You can, but there is no evidence that combining them provides additive benefits beyond what either one achieves alone. Since NR must be converted to NMN before becoming NAD+ anyway, combining them likely just increases total precursor intake without unique synergy. It is more practical and cost-effective to optimize the dose of one precursor.

Why does David Sinclair prefer NMN?

Harvard geneticist David Sinclair has publicly stated he takes NMN, which has significantly influenced consumer preference. His reasoning centers on NMN's more direct conversion to NAD+ and the identification of a potential NMN-specific transporter (Slc12a8). However, Sinclair's expertise is primarily in mouse models, and he acknowledges that definitive human longevity data is still forthcoming for both NMN and NR.

References

  1. (). The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. GeroScience. DOI
  2. (). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. DOI
  3. (). Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism. DOI